Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q4 EPS of ($0.52), $0.63 better than the analyst estimate of ($1.15).

For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.